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Two distinctive chronic wasting disease isolates identified in captive elk
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ABSTRACT

ARTICLE HISTORY

Chronic wasting disease (CWD) continues to spread in both wild and captive cervid herds in North
America and has now been identified in wild reindeer and moose in Norway, Finland and Sweden.
There is limited knowledge about the variety and characteristics of isolates or strains of CWD that
exist in the landscape and their implications on wild and captive cervid herds. In this study, we
evaluated brain samples from two captive elk herds that had differing prevalence, history and
timelines of CWD incidence. Site 1 had a 16-year history of CWD with a consistently low
prevalence between 5% and 10%. Twelve of fourteen naïve animals placed on the site remained
CWD negative after 5 years of residence. Site 2 herd had a nearly 40-year known history of CWD
with long-term environmental accrual of prion leading to nearly 100% of naïve animals develop
ing clinical CWD within two to 12 years. Obex samples of several elk from each site were
compared for CWD prion strain deposition, genotype in prion protein gene codon 132, and
conformational stability of CWD prions. CWD prions in the obex from site 2 had a lower con
formational stability than those from site 1, which was independent of prnp genotype at codon
132. These findings suggest the existence of different CWD isolates between the two sites and
suggest potential differential disease attack rates for different CWD strains.
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Introduction
Transmissible spongiform encephalopathies (TSEs) are
infectious neurodegenerative diseases, also referred to as
prion diseases that affect a number of mammals, such as
humans, sheep, goats, cattle, cervids, minks, and felines.
Chronic wasting disease (CWD) is a prion disease of ani
mals in the family Cervidae. Natural transmission of CWD
has been detected thus far in deer, elk, reindeer, and moose,
and the disease continues to expand in wild and captive
populations throughout the United States and Canada
[1,2]. CWD has also been detected in wild moose and
reindeer in Norway, Finland and Sweden [3]. Although
CWD has been well documented and studied since the
1960s, there is still much unknown about it [4]. One such
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aspect is the prevalence and identification of distinctive
isolates or strains, of the disease within and among species.
Unlike strains in bacterial or viral diseases, the pre
sence of strains in prion diseases is not determined by
genetic variability or mutations within the infectious
organism itself because the infectious agent is an aber
rantly folded endogenous protein [5,6]. The term
‘strain’ is found in the prion disease literature to
describe variations in clinical signs, incubation period,
distribution of the misfolded prion (PrPRES) in the
body, and the stability of the PrPRES protein within
the same species and TSE type [7–13]. Strains have
been documented in other prion diseases (e.g., scrapie,
transmissible mink encephalopathy, bovine spongiform
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encephalopathy, Creutzfeldt-Jakob disease) and signifi
cant evidence indicates they are present in CWD as
well, but it remains unclear as to how many exist and
how they present in cervids [11,14–19]. Laboratory
studies utilizing transgenic mice suggest that multiple
CWD strains likely exist [10,20,21].
Here, we report that CWD appears to behave differ
ently in two spatially disjunct, naturally infected captive
elk populations, which precipitated comparative bio
chemical analysis of the CWD prions in animals from
the two sites. Our results from these analyses confirm
that the CWD prions at these two sites are different.

Methods and materials
Study animals
Elk in this study were from two captive, CWD-positive
herds in the western United States where disease expo
sure occurred through natural routes. The tissues
examined from these herds were comprised of both
archived fixed and archived frozen brain samples
from individuals that were found to be positive for
CWD by immunohistochemical analysis of the obex
and/or medial retropharyngeal lymph nodes. Specifics
on animals and study sites are described below.
Site 1
Site 1 housed approximately 35 captive elks at any 1
time on 4.7 ha over a sixteen-year period and had
a consistent annual CWD prevalence rate of 5–10%
(2–3 positive animals), as established by rectal biopsy
and post-mortem testing. This location was devoid of
vegetation and was composed of rocky terrain and
exposed soil.
CWD isolate study animals. Brains from two CWDinfected terminal-stage adults from this site were sub
jected to biochemical analysis. Animal 1-A was a sevenyear-old adult male, and animal 1-B was a five-year-old
adult female (Table 1).
Introduction of naïve animals. The animals were
housed and euthanized in accordance with the
Table 1. Study animal location, ID, sex, and PrP genotypes in
codon 132 (M. methionine; L. leucine) for CWD isolate
evaluation.
Animal Site and ID
1-A
1-B
2-A
2-B
2-C
2-D

Sex
M
F
F
F
F
F

Age
7 yr
5 yr
Adult
Adult
Adult
Adult

Genotype at codon 132
ML
MM
MM
MM
ML
ML

USDA National Wildlife Research Center IACUC
committee requirements. Thirteen one-year-old
CWD-naïve male and 1 one-year-old CWD-naïve
female elk were introduced to Site 1 to evaluate
direct and indirect CWD transmissions (Table 2).
Elks were purchased from a captive, CWD-negative
herd in Minnesota in an area not reported to have
CWD in the wild. Upon arrival, all elk had blood
drawn for genotyping at PrP codon 132 by the USDA
Agricultural Research Service in Pullman, WA, and
were tested by rectal biopsy immunohistochemistry
(IHC) for CWD. Six males were placed in a 0.1-ha
pen where CWD-positive animals had been pre
viously housed to investigate the potential for indir
ect transmission of CWD. The pen was doublefenced to prevent nose-to-nose contact with the rest
of the population. The remaining seven males were
integrated into the established main population to
investigate direct transmission; the female was cohoused with an 11-year-old female who was a longstanding member of the herd. Animals were ante
mortem tested via rectal biopsy as previously
described [22], once a year throughout the five-year
study period. Any animals found to have positive
PrPRES IHC staining in the rectal biopsy sample
were euthanized within a week of detection.
Site 2
Site 2 maintained between 10 and 100 elks in eight
separate 0.2-ha pens during a 60-year time period.
Other cervids including mule deer, white-tailed deer,
and moose were also held at the facility. Multiple nat
ural exposure CWD studies were conducted at the
facility, and animals were often allowed to reach endstage disease for various research projects [4,23–26].
Elks were typically rotated between pens and alleyways
Table 2. Site 1 direct and indirect contact animals. group, ID,
sex, incubation period (if applicable), CWD status at death, and
PrP genotypes at codon 132 (M, methionine; L, leucine).
Site 1 Indirect Contact
Pen Animal ID
S11
44 T
51 T
806 T
808 T
814 T
Site 1 Direct Contact
Pens Animal ID
S12
S13
58 T
800 T
801 T
802 T
803 T
840 T

Sex
M
M
M
M
M
M

Incubation
period
>5 years
>5 years
>5 years
>5 years
>5 years
>5 years

Sex
M
F
M
M
M
M
M
M

Age
>5 years
1 year
>5 years
>5 years
3 years
>5 years
>5 years
>5 years

CWD Status
at death
Non-detect
Non-detect
Non-detect
Non-detect
Non-detect
Non-detect
CWD Status
at death
Non-detect
Positive
Non-detect
Non-detect
Positive
Non-detect
Non-detect
Non-detect

Genotype at
codon 132
ML
MM
MM
MM
MM
MM
Genotype at
codon 132
LL
MM
MM
MM
MM
MM
MM
MM
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to allow for periodic grazing but were often held in
pens devoid of vegetation with exposed soil. CWD was
first documented at Site 2 in 1979; however, earlier
cases may have been missed prior to the discovery
and characterization of the disease. Annual prevalence
rates were not established for this site in the same
manner as Site 1. However, mortality testing revealed
a significantly higher incidence of CWD than at Site 1.
Periodic introduction of CWD-naïve animals to Site 2
was not part of this study, and animals were utilized for
a variety of research purposes over many decades.
These animals were not always introduced into preexisting CWD-positive herds but were often kept iso
lated in enclosures that had previously housed CWDpositive animals; however, contact between groups
through gates and pens routinely occurred unless spe
cific isolation protocols were in place for research pro
jects. Animals with the codon 132 MM genotype
typically reside on site for 2 to 7 years before becoming
clinical for CWD. Animals with the ML genotype
tended to survive longer and had an average lifespan
of four to 9 years [26,27].
CWD isolate study animals. The brains of four CWDinfected terminal stage adult females of unknown age
[2-A, 2-B, 2-C, 2-D] from this site were subjected to
biochemical analysis (Table 2).
Introduction of naïve animals. Elks were added to the
site over a 60-year time period for various reasons and
from multiple sources, including wild-captured adults
from within the same state, such as orphaned neonates,
6–8 month old elk calves, or natural additions from the
resident population. Naïve animals introduced to this
site were not part of the study and are mentioned
simply to increase understanding of the location
history.
Sequencing of functional PrP genes
Genomic DNA was purified from frozen brain tissues
using a standard phenol-chloroform extraction proce
dure. The purified DNA samples were subjected to two
more rounds of phenol/chloroform extraction to remove
any residual prions before further manipulations. The
PrP-coding region from functional PrP genes was ampli
fied by PCR (95°C for 4 min; 35 cycles of 95°C for 30 sec,
54°C for 30 sec and 72°C for 60 sec; followed by 72°C for
10 min) using the Phusion high fidelity polymerase (New
England Biolabs, Ipswich, MA, USA) and primers
DePrP223
(ACACCCTCTTTATTTTGCAG)
and
DePrP224 (AGAAGATAATGAAAACAGGAAG) that
had been previously phosphorylated by T4
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polynucleotide kinase (New England Biolabs, Ipswich,
MA, USA). The PCR products were recovered after gel
electrophoresis in 1% agarose gels using the QIAquick gel
extraction kit (Qiagen, Hilden, Germany), cloned into
the EcoRV site of pstBlue-1, transformed into E coli.
and the plasmid DNA extracted with the PureLink
Quick Plasmoid Miniprep Kit (Invitrogen. Carlsbad,
CA, USA). The purified PCR products and the cloned
plasmids were subjected to sequencing by MCLAB
(South San Francisco, CA, USA) using primers
DePRP223 and DePrP224. The final PrP genotypes
were determined based on a combination of sequencing
traces from the PCR products and sequences of multiple
clones from each elk DNA sample.
Fibril stability assay
The IDEXX HerdChek BSE-Scrapie Antigen EIA test
kit selectively binds and detects PrPRES as opposed
to the normal endogenous cellular prion protein
(PrPC) or unfolded PrP. We used this kit to measure
the amount of PrPRES in tissue samples after incu
bation in GdnHCl as described in Vrentas et al. [9].
Briefly, the brain stem samples stored at −80°C were
homogenized at 20% (w/v) in 1 x PBS (Dulbecco ,
pH 7.4, no calcium and magnesium) and incubated
in 0.25–4.0 M GdnHCl, 1 x PBS for 1 hr. The
amount of brain homogenate used in each sample
was adjusted to ensure that the final optical density
at 450 nm (OD450) of the EIA was at or near 1.0
and involved a minimum of 1 to 10 dilutions into
the buffered GdnHCl containing solution. Following
the 1-hr incubation, all samples were diluted with
PBS for a final GdnHCl concentration of 0.25 M
and loaded onto the EIA test kit plates. Sample
analysis subsequently followed the manufacturer’s
‘short protocol’ for small ruminants. OD450 values
for each sample were determined and normalized to
either the 0.25 M or 1.0 M sample following sub
traction of the IDEXX kit provided negative control.
The unfolding curve for each animal was repeated 3
times, the Cmid (denaturant concentration at the
midpoint of unfolding) determined by visual inspec
tion, and the mean for each determined. The aver
age Cmid for each site is then determined as the
average across animals. A two-tailed t-test was
used to determine the significance between the
unfolding curves from each site.
Western blot analysis
The brain samples were homogenized at 20% in 1x PBS
(pH 7.4, without calcium and magnesium) and stored at
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−80°C before examination. Before the Western blot, the
frozen 20% brain homogenate was thawed; 50ul was
taken, mixed with an equal volume of 2x lysis buffer
[200 mM NaCl, 200 mM Tris-HCL (pH 8.0), 20 mM
EDTA, 1% NP-40, 1% sodium deoxycholate] to get 10%
brain homogenate in 1x lysis buffer, which was then
incubated at −80°C for at least 12 hours. After thawing
on ice, the 10% brain homogenate in the lysis buffer was
briefly sonicated (about 10 s), centrifuged for 8 minutes
at 500 g at 4°C, and the supernatant carefully transferred
to a fresh tube. Aliquot of the supernatant (1–2.5 ul for
elk samples and 15ul for human sCJD type 1 and type 2
controls) was taken, and 10% brain homogenate from
FVB/PrPKO mice was added to the elk sample tubes to
obtain a total of 15 ul of brain homogenate for each
sample tube; this was done to ensure highly similar
total protein contents in each sample tube for the sub
sequent proteinase K (PK) digestion and comparable
PrPSc signals for all samples. PK was added to a final
concentration of 100 µg/ml, and the digestion was per
formed for 1 hr at 37°C in a heat-block, with vigorous
shaking. In the addition of 15 ul of Tricine loading buffer
(BioRad, Cat. No. 1,610,739), the samples were boiled at
100°C for 10 min, separated on 16.5% Criterion TrisTricine SDS-PAGE gels (Biorad, Cat. No. 3,450,064) and
transferred onto a polyvinylidene difluoride (PVDF)
membrane (Millipore, Billerica, MA) for 2 h at 0.5 A.
The membranes were probed with anti-PrP primary anti
bodies (8H4, 1:5000; 9A2, 1:4000; or POM19, 1:500) and
sheep anti-mouse IgG conjugated with horseradish per
oxidase (Amersham, Cat. No. NA931) as the secondary
antibody and developed with the ECL2 Western blotting
substrate (Thermo Scientific, PI80196) for 5 minutes and
then developed using Carestream Biomax Xar film
(Sigma 165–1454).

Results
Sequencing of functional PrP genes in the elk
samples
The functional PrP gene sequences in the elk samples
were determined by sequencing the PCR product of
the PrP ORFs and multiple clones of the PrP ORF
PCR products for each sample. Site 1 animal A was
methionine/leucine (ML), and animal B was methio
nine/methionine (MM) at codon 132. Site 2 animals
A and B were MM, while C and D were ML at codon
132 (Table 2). Introduced naïve animals to Site 2
were not part of this study, and their genetics are
unknown.

Direct and indirect contact groups on site 1
A year after its introduction, the female, MM, direct
contact elk (S13) was found to be CWD-positive by
rectal biopsy and was euthanized. The ‘native’ 11-yearold female that she was co-housed with was also found
to be CWD-positive by rectal biopsy at the same time.
Neither was clinical. Three years after the introduction,
an asymptomatic, direct contact, MM male (801 T) was
found to be CWD positive by rectal biopsy. After 5
years, the introduction aspect of the study at Site 1 was
terminated. All-remaining animals, who were in excel
lent body condition and showed no clinical signs of
CWD, were euthanized, necropsied, and tested for
CWD by IHC. All the remaining males (indirect
group n = 6 and direct group n = 6) were non-detect
for CWD by IHC in medial retropharyngeal lymph
nodes and obex, the only tissues examined.
Fibril stability
The fibril stability assay indicated that Site 1 animal
samples had a discernibly higher resistance to unfold
ing by the chemical denaturant GdnHCl when com
pared with those of Site 2 animal samples, with the
mean midpoint of the unfolding curves at 2.53 M and
2.12 M, respectively (Figure 1). The difference in fibril
stability between prions in animals from the two sites is
statistically significant (p = 0.0043) (Figure 1b).
Western blot
The band pattern of the CWD PrPRES in Western Blot
was indistinguishable between the two groups when
probed with three different antibodies that target dif
ferent regions of the PrP protein (Figure 2).

Discussion
The observation that CWD appears to behave differ
ently between two naturally infected captive elk popu
lations precipitated a biochemical analysis to look for
biochemical differences in the CWD prion proteins
present in animals on these sites.
One biochemical method of differentiating prion
isolates or strains is to evaluate the stability of the
aberrant prion protein’s structural conformation uti
lizing a denaturing agent such as GdnHCl. The more
stable a conformation, the greater the concentration
of GdnHCl required to denature the protein.
Previous work has shown that TSEs with greater
prion stability exhibited longer incubation periods
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Figure 1. The fibril stability of PrPSc from the two sites are different. (a) Representative fibril stability curves for samples from sites 1
and 2. The connecting lines are presented to aid the eye and highlight the point at which each unfolding curve intersects a fraction
fibril of 0.5. Both Site 1-A and Site 1-B samples exhibit visibly higher fibril stability than the Site 2 samples based upon the
concentration of GdnHCl at which the fraction fibril reaches 0.5 (Cmid). (b) Bargraph of quantified Cmid values of the site 1 and site 2
samples. The average Cmid value of site 1 samples (2.53 ± 0.05 M) is significantly higher than that of site 2 samples (2.16 ± 0.09 M)
(p = 0.0043).

than those with lower stability when bioassayed
experimentally in the laboratory [9,28,29].
Conversely, a study utilizing hamsters reported the
opposite, with the more stable PrPRES conveying
a shorter incubation period [7]. Site 1 had a history
of a low prevalence rate of CWD with one or two
animals diagnosed per year (5–10%), and a CWD
isoform with greater conformational stability as com
pared to Site 2. The relatively low prevalence rate
does not appear to be a result of an increased incuba
tion period, but rather a limited attack rate as illu
strated by the direct and indirect contact findings. Six
of the seven naïve elk co-housed with the resident
herd remained free of CWD 5 years after its intro
duction. In contrast, Site 2 had a higher prevalence of

CWD cases with all elk eventually becoming CWD
positive with a CWD isoform that was less stable. The
difference in history and timeline of CWD between
the two facilities must be noted; however, as there
was longer-term CWD contamination and accumula
tion at Site 2. While high animal and environmental
CWD burden may be responsible for this level of
CWD prevalence, it does not account for the differ
ence in prion conformational stability. It has been
hypothesized that prion strains may change over
time. At site 2, perhaps a more infectious isoform
(s)/strain(s) may have emerged at some point and
become dominant at the site over time. The data
from this study seem to support the above notion
considering CWD positive animals had been housed
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Figure 2. Western blot of CWD PrPRES in the brain tissues from Sites 1 and 2 elk. Four anti-PrP antibodies that target different PrP
epitopes were used: 9A2 (epitope 97–115), 8H4 (epitope 177–180), and POM19 (epitope 201–225). POM19 does not recognize
human PrP whereas 9A2 shows higher affinity for type 1 PrPRES. T1 and T2 are type 1 sCJD and type 2 sCJD human brain tissue
controls, respectively. ‘CWD’ is a positive control elk CWD brain sample from an unrelated study. The loading amount was adjusted
between the brain samples to allow more comparable signal strength for all samples with the same exposure: 5ul of 5% brain
homogenate for 1-B, 1-A, 2-C and 2-A; 2ul of 5% brain homogenate for 2-D, 2-B and the control ‘CWD’ samples; 30ul of 5% brain
homogenate for T1 and T2 human sCJD controls. The difference in sample loading volume was made up with 5% brain homogenate
from PrPKO/FVB mice.

at Site 2 for decades and had a high level of transmis
sion. More focused studies will need to be done to
explore this idea further.
Animal 2-B had a different denaturation pattern
than the other Site 2 CWD samples. Animal 2-B’s
CWD remained stable until the GdnHCl concentration
reached 2 M, after which there was a precipitous
decline in stability. In contrast, the other three Site 2
CWD samples began to lose stability at 1 M and con
tinued to lose stability in a less abrupt manner. The
significance of this difference is unclear.
Western blot analysis of the samples did not reveal
any significant molecular weight or band pattern
changes between the CWD isoforms despite utilizing
three different anti-PrP antibodies. These findings
demonstrate that different prion isolates can behave
very similarly in Western Blots.
Genetic polymorphisms in codon 132 of the prion
protein gene (prnp) have been shown to strongly

influence the proliferation and incubation period of
CWD in elk [30,31]. The most common genotype in
wild elk at codon 132 is methionine/methionine (MM)
[32]. These animals have decreased incubation times
and thus faster disease proliferation than methionine/
leucine (ML) or leucine/leucine (LL) genotypes.
However, genotypes at codon 132, MM or ML,
appeared to have no influence on the stability of
prion fibrils in this study, with stability differing by
site rather than by genotype. Of the surviving 12 ani
mals in the direct and indirect contact study at Site 1,
10 were MM at codon 132. In contrast, CWD positive
MM animals from Site 2 had a typical life span of two
to 3 years. In a study examining different CWD strains
in Syrian golden hamsters, the authors concluded that
the observed differences in the prion strain in their
model were independent of prion gene polymorphisms
[28]. Our findings are consistent with this and those of
Moore, et al. who found no difference in fibril stability
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between experimentally CWD-infected MM and ML
elk [31].
In this study, we use the term isolate to describe our
findings versus strain, as we were unable to conduct
transgenic mouse bioassay, and lacked tissues to com
pare brain and organ pathology to address all the pre
viously described criteria for a prion strain, such as
variations in clinical signs, incubation period, distribu
tion of the misfolded prion (PrPRES) in the body, and
the stability of the PrPRES protein within the same
species and TSE type. Despite this, we feel that the
data we have strongly suggest the presence of two
different CWD strains.
It is clear from looking at the literature that the
phenomenon of strains or isolates in prion diseases is
complex. Studies have shown that multiple prion
strains can be present in a single sample and that
the ratio of strains presents in the sample may alter
which form becomes dominant [10,12,33,34].
Furthermore, multiple strains can sometimes inter
fere with one another, resulting in the dominance of
one type over another [35–37], and interaction
between infectious prions and soil can alter which
form becomes dominant over time, suggesting a role
for environmental factors in this selection process
[38]. Both the cloud hypothesis and the deformed
template theory of prion propagation suggest that
the replication environment ultimately determines
the final confirmation of the de novo prions by either
making conditions more conducive to one strain over
the other (cloud hypothesis) or by directly influencing
the de novo development itself (deformed template
theory) [39,40]. The replication environment referred
to in these hypotheses is the region of replication
within the body of the animal. Previous work con
ducted in our laboratory, utilizing a cervidized trans
genic mouse model, demonstrated that altering this
internal environment, by increasing or decreasing
copper consumption, affected neuroinflammatory
gene expression and the CWD incubation period in
the mice [41]. It is unclear if exogenous factors, such
as cation ingestion or soil type, played a role in the
development of the different isoforms we detected.
Because the sample numbers in this study were low,
stronger conclusions could not be drawn. However, our
findings suggest that prion isoforms may influence the
infectivity of the CWD prion and thus how the disease
behaves in the landscape. It is our hope that these
findings add another piece to the puzzle of CWD
prion diversity and the potential evolution of CWD
prions over time. More research is needed to under
stand the role and significance of CWD isoforms in
disease transmission.
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